Beacon Pharmaceuticals PLC announcements
252 Dhaka Stock Exchange announcements for Beacon Pharmaceuticals PLC (BEACONPHAR) since 2010: results, dividends, board meetings, AGMs, record dates and other price-sensitive information. Showing 2017 (17).
- Credit Rating Result
Credit Rating Agency of Bangladesh Limited (CRAB) has announced the Entity (surveillance) Rating of the Company as "BBB1" based on audited financial statements up to June 30, 2017; bank liability position as on September 30, 2017 and other relevant quantitative as well as qualitative information up to the date of rating declaration.
- Resumption after record date
Trading of the shares of the Company will resume on 21.11.2017 after record date.
- Suspension for Record Date
Trading of the shares of the Company will remain suspended on record date i.e., 20.11.2017.
- Q1 Financials
(Q1 Un-audited): EPS was Tk. 0.10 for July-September, 2017 as against Tk. 0.05 for July-September, 2016; NOCFPS was Tk. 0.44 for July-September, 2017 as against Tk. 0.70 for July-September, 2016. NAV per share was Tk. 12.96 as on September 30, 2017 and Tk. 13.10 as on September 30, 2016.
- Spot News
Trading of the shares of the Company will be allowed only in the Spot Market and Block transactions will also be settled as per Spot settlement cycle with cum benefit from 16.11.2017 to 19.11.2017. Trading of the shares of the Company will remain suspended on record date i.e., 20.11.2017.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2017 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2017.
- Dividend Declaration
The Board of Directors has recommended 5% cash dividend for the year ended on June 30, 2017. Date of AGM: 28.12.2017, Time: 11:00 AM, Venue: Registered Office at Kathali, Bhaluka, Mymensingh (Factory Premises). Record date: 20.11.2017. The Company has also reported EPS of Tk. 0.45, NAV per share of Tk. 12.95 and NOCFPS of Tk. 4.25 for the year ended on June 30, 2017 as against Tk. 0.27, Tk. 13.00 and Tk. 2.41 respectively for the same period of the previous year.
- Price Limit Open
There will be no price limit on the trading of the shares of the Company today (23.10.2017) following its corporate declaration.
- Board Meeting schedule under LR 19(1)
As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on October 22, 2017 at 3:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2017.
- Address Change of Corporate Office and Share Department
The Company has informed that Corporate Office including share department of the Company has been shifted to its own building at Beacon Business Centre, 9/A, Toyenbee Circular Road, Motijheel C/A, Dhaka-1000.
- Q3 Financials
(Q3 Un-audited): EPS was Tk. 0.13 for January-March, 2017 as against Tk. 0.03 for January-March, 2016. EPS was Tk. 0.27 for July, 2016-March, 2017 as against Tk. 0.15 for July, 2015-March, 2016. NOCFPS was Tk. 1.67 for July, 2016-March, 2017 as against Tk. 0.73 for July, 2015-March, 2016. NAV per share was Tk. 12.77 as of March 31, 2017 and Tk. 12.73 as of March 31, 2016.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on April 29, 2017 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Third Quarter (Q3) period ended on March 31, 2017.
- Q2 Financials
(Q2 Un-audited): EPS was Tk. 0.09 for October-December, 2016 as against Tk. 0.08 for October-December, 2015; EPS was Tk. 0.14 for July-December, 2016 as against Tk. 0.12 for July-December, 2015. NOCFPS was Tk. 1.16 for July-December, 2016 as against Tk. 1.39 for July-December, 2015. NAV per share was Tk. 13.13 as of December 31, 2016 and Tk. 12.70 as of December 31, 2015.
- Dividend Disbursement
The Company has informed that it has disbursed dividend warrants for the year ended on June 30, 2016 to the shareholders at their mailing address accordingly.
- Category Change
The Company will be placed in 'B' category from existing 'Z' category with effect from January 29, 2017 as the Company has reported disbursement of 5% cash dividend for the year ended on June 30, 2016.
- Prohibition on providing loan facilities to purchase securities
The Stock Brokers, Merchant Bankers and Portfolio Managers are requested to abstain from providing loan facilities to purchase any security of Beacon Pharmaceuticals Limited in between 1st to 30th trading day after change of categorization, with effect from January 29, 2017 as per BSEC Directive No. SEC/CMRRCD/2009-193/177 and BSEC Order No. SEC/CMRRCD/2009-193/178 dated October 27, 2015.
- Board Meeting schedule under LR 16(1)
As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on January 30, 2017 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the Second Quarter (Q2) period ended on December 31, 2016.
Source: Dhaka Stock Exchange announcements. Some posts before 2014 have no title, and 2014–2020 coverage is incomplete.